Skip to main content
. 2016 Apr 6;4:7. doi: 10.1186/s40170-016-0147-7

Table 2.

Hazard ratios for the association between RBG (≥120 vs. <120) and breast cancer outcomes

Overall survival HR (95 % CI) P value
 Crude 3.01 (1.70–5.33) <0.001
 Adjusted for age 2.99 (1.68–5.33) <0.001
 Adjusted for age group (≥50 vs. <50) 3.07 (1.72–5.48) <0.001
 Adjusted for grade 3.08 (1.71–5.57) <0.001
 Adjusted for stage 3.09 (1.73–5.53) <0.001
 Adjusted for age, tumor grade and tumor stage 3.19 (1.74–5.86) <0.001
 Adjusted for age, tumor grade, tumor stage, and race 3.24 (1.75–5.99) <0.001
 Adjusted for age group (≥50 vs. <50), tumor grade, tumor stage, and race 3.40 (1.83–6.33) <0.001
 Adjusted for BMI 3.24 (1.78–5.89) <0.001
 Adjusted for tumor grade, tumor stage, race, and BMI 3.50 (1.87–6.54) <0.001
Time to tumor recurrencea
 Crude 2.08 (1.04–4.16) 0.039
 Adjusted for age 2.59 (1.27–5.26) 0.009
 Adjusted for age group (≥50 vs. <50) 2.65 (1.29–5.44) 0.008
 Adjusted for grade 2.06 (1.01–4.18) 0.046
 Adjusted for stage 2.01 (1.00–4.04) 0.051
 Adjusted for grade and stage 2.00 (0.97–4.09) 0.059
 Adjusted for race 2.17 (1.08–4.38) 0.030
 Adjusted for BMI 2.37 (1.16–4.83) 0.017
 Adjusted for BMI and grade 2.32 (1.13–4.73) 0.021
 Adjusted for BMI and stage 2.32 (1.13–4.76) 0.022

aFive out of 148 (3.4 %) subjects who never became disease free were removed from TTR analyses